Yamashita T, Murakawa Y, Ajiki K, Omata M
Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
Am J Cardiol. 1996 Jun 15;77(15):1365-7. doi: 10.1016/s0002-9149(96)00208-1.
In summary, CL modulates the dispersion in refractoriness of triple nodal pathways by causing greater changes in refractoriness in the slower pathways and thus determines the feasibility of manifestation.
总之,CL通过使较慢传导通路的不应期产生更大变化来调节三结区传导通路不应期的离散度,从而决定了显性预激的可行性。